WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 2 fonti

This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Friday - Centene (NY

Analysts changed outlook on top names, including SMMT, DAVA. See what others think before buying SMMT stock.

Raccontata da

markets.businessinsider.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo2 g fa

This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Friday - Centene (NY

Analysts changed outlook on top names, including SMMT, DAVA. See what others think before buying SMMT stock.

markets.businessinsider.com3 g fa

Bernstein starts Summit with an Underperform, says ‘not on solid footing’

Bernstein analyst Jeffrey Walch initiated coverage of Summit Therapeutics (SMMT) with an Underperform rating and $7.70 price target The firm re...

Leggi questa versione → originale

Timeline cronologica

giovedì 21 maggio 2026·markets.businessinsider.com
Bernstein starts Summit with an Underperform, says ‘not on solid footing’
Bernstein analyst Jeffrey Walch initiated coverage of Summit Therapeutics (SMMT) with an Underperform rating and $7.70 price target The firm re...
venerdì 22 maggio 2026·benzinga.com
This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Friday - Centene (NY
Analysts changed outlook on top names, including SMMT, DAVA. See what others think before buying SMMT stock.